Bio-Connect
IHC-P analysis of human heart tissue using GTX31308 PD-L1 antibody. Working concentration : 20 microg/ml
IHC-P analysis of human heart tissue using GTX31308 PD-L1 antibody. Working concentration : 20 microg/ml
IHC-P analysis of human heart tissue using GTX31308 PD-L1 antibody. Working concentration : 20 microg/ml

PD-L1 antibody

GTX31308
GeneTex
ApplicationsFlow Cytometry, Western Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetCD274
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    PD-L1 antibody - KO/KD, Overexpression Validated
  • Delivery Days Customer
    9
  • Antibody Specificity
    PD-L1 antibody has no cross-reactivity to PD-L2.
  • Application Supplier Note
    WB: 0.5 - 1 microg/mL. IHC-P: 2.5 microg/mL. FACS: 0.5 microg/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Flow Cytometry, Western Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID29126
  • Target name
    CD274
  • Target description
    CD274 molecule
  • Target synonyms
    B7 homolog 1; B7-H; B7H1; CD274 antigen; hPD-L1; PDCD1 ligand 1; PDCD1L1; PDCD1LG1; PDL1; PD-L1; programmed cell death 1 ligand 1
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDQ9NZQ7
  • Protein Name
    Programmed cell death 1 ligand 1
  • Reactivity
    Human, Mouse, Rat
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • PD-L1-mediated immune evasion in triple-negative breast cancer is linked to the loss of ZNF652.
    Read more
  • WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression. Wu M et al., 2021 Jun 9, Nat Commun
    Read more
  • Inhibition of TRPV1 by SHP-1 in nociceptive primary sensory neurons is critical in PD-L1 analgesia. Liu BL et al., 2020 Oct 15, JCI Insight
    Read more
  • The extracts of Astragalus membranaceus overcome tumor immune tolerance by inhibition of tumor programmed cell death protein ligand-1 expression. Chang HL et al., 2020, Int J Med Sci
    Read more
  • NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer. Qin G et al., 2020 Apr 3, Nat Commun
    Read more
  • The prediction of survival of patients with gastric cancer with PD-L1 expression using contrast-enhanced ultrasonography. Wang LA et al., 2016 Jun, Tumour Biol
    Read more